Biotech · Public company · Hayward, CA, US
Benitec Biopharma Inc.
Ticker BNTC · SEC CIK 0001808898
Track this companyFree. Adds Benitec Biopharma Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline4
- BB-301: Dose escalation phase 1b cohort 1Phase 2 · Oculopharyngeal Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- BB-301: Dose escalation phase 1b cohort 2Phase 2 · Oculopharyngeal Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- BB-301: Dose escalation phase 1b cohort 3Phase 2 · Oculopharyngeal Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- BB-301: Dose expansion phase 2aPhase 2 · Oculopharyngeal Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With DysphagiaPHASE1_PHASE2 · RECRUITING · started Nov 28, 2023ClinicalTrials.gov NCT06185673 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 24, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 10-K/A · 10-K/ASEC EDGAR · filed Mar 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Feb 12, 2026 · fetched Nov 12, 2026